{
    "title": "South African drugmaker Aspen expects coronavirus impact",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8079275/South-African-drugmaker-Aspen-expects-coronavirus-impact.html",
    "date": "2020-03-05",
    "keywords": [
        "drugmaker",
        "manufacturing",
        "revenue",
        "coronavirus",
        "performance",
        "firm",
        "heparin",
        "dludla",
        "half",
        "year",
        "outbreak",
        "statement",
        "impact",
        "china",
        "business",
        "johannesburg",
        "march",
        "rise",
        "thursday",
        "interest",
        "tax",
        "depreciation",
        "amortization",
        "ebitda",
        "aspen",
        "unit",
        "restart",
        "share",
        "lift",
        "net",
        "financing",
        "presence",
        "team",
        "date",
        "inventory",
        "reliance",
        "ingredient",
        "api",
        "risk",
        "assessment",
        "basis",
        "opportunity",
        "guidance",
        "line",
        "pharma",
        "oncology",
        "portfolio",
        "focus",
        "growth",
        "resumption",
        "bloodthinner",
        "rand",
        "availability",
        "result",
        "swine",
        "fever",
        "pork",
        "producer",
        "debt",
        "leverage",
        "ratio",
        "measure",
        "ability",
        "threshold",
        "redesign",
        "procurement",
        "clarke",
        "lisa",
        "shumaker"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}